Notice Number: NOT-HL-11-161
Release Date: December 13, 2011
National Heart, Lung, and Blood Institute (NHLBI)
On November 30, 2011, the NHLBI issued a Funding Opportunity Announcement (FOA): PAR-12-043 (Identifying Heart, Lung, and Blood Disease-Causing Variants (R01)) https://grants.nih.gov/grants/guide/pa-files/PAR-12-043.html.
The following corrections to this FOA are being made:
Section III. Eligibility InformationSection IV. Application and Submission Information
1. Eligible Applicants
Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Although a letter of intent is not required, is not binding, and does not enter into the review of a subsequent application, the information that it contains allows IC staff to estimate the potential review workload and plan the review.
By the date listed in Part 1. Overview Information, prospective applicants are asked to submit a letter of intent that includes the following information:
Descriptive title of proposed research
Name, address, and telephone number of the PD(s)/PI(s)
Names of other key personnel
Number and title of this funding opportunity
The letter of intent should be sent to:
Director, Office of Scientific Review
Division of Extramural Research Activities
National Heart, Lung, and Blood Institute
6701 Rockledge Drive, Room 7214, MSC 7924
Bethesda, MD 20892-7924 (Express Mail Zip: 20817)
Telephone: 301) 435-0270
Fax: (301) 480-0730
Inquiries should be directed to:Deborah Applebaum-Bowden, Ph.D.
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
Office of Extramural
National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
Department of Health
and Human Services (HHS)
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.